Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines

被引:138
作者
Herrmann, CH
Carroll, RG
Wei, P
Jones, KA
Rice, AP
机构
[1] Baylor Coll Med, Div Mol Virol, Houston, TX 77030 USA
[2] HM Jackson Fdn, Mil HIV Res Program, Bethesda, MD 20889 USA
[3] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA
关键词
D O I
10.1128/JVI.72.12.9881-9888.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
TAK, a multisubunit cellular protein kinase that specifically associates with the human immunodeficiency virus Tat proteins and hyperphosphorylates the carboxyl-terminal domain of RNA polymerase II, is a cofactor for Tat and mediates its transactivation function. The catalytic subunit of TAK has been identified as cyclin-dependent kinase Cdk9, and its regulatory partner has been identified as cyclin T1; these proteins are also components of positive transcription elongation factor P-TEFb. TAK activity is up-regulated upon activation of peripheral blood lymphocytes and following macrophage differentiation of promonocytic cell lines. We have found that activation of peripheral blood lymphocytes results in increased mRNA and protein levels of both Cdk9 and cyclin TI. Cdk9 and cyclin T1 induction occurred in purified CD4(+) primary T cells activated by a variety of stimuli. In contrast, phorbol ester-induced differentiation of promonocytic cell lines into macrophage-like cells produced a large induction of cyclin T1 protein expression from nearly undetectable levels, while Cdk9 protein levels remained at a constant high level. Measurements of cyclin T1 mRNA levels in a promonocytic cell line suggested that regulation of cyclin T1 occurs at a posttranscriptional level. These results suggest that cyclin T1 and TAK function may be required in differentiated monocytes and further show that TAK activity can be regulated by distinct mechanisms in different cell types.
引用
收藏
页码:9881 / 9888
页数:8
相关论文
共 43 条
[1]  
BURGER C, 1994, J CELL SCI, V107, P2047
[2]   Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1 [J].
Chun, RF ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) :27888-27894
[3]  
COLLINS SJ, 1987, BLOOD, V70, P1233
[4]   The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II [J].
Cujec, TP ;
Okamoto, H ;
Fujinaga, K ;
Meyer, J ;
Chamberlin, H ;
Morgan, DO ;
Peterlin, BM .
GENES & DEVELOPMENT, 1997, 11 (20) :2645-2657
[5]   HIV-1 auxiliary proteins: Making connections in a dying cell [J].
Cullen, BR .
CELL, 1998, 93 (05) :685-692
[6]   PHOSPHORYLATION OF THE C-TERMINAL DOMAIN OF RNA-POLYMERASE-II [J].
DAHMUS, ME .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1261 (02) :171-182
[7]   HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology [J].
Emerman, M ;
Malim, MH .
SCIENCE, 1998, 280 (5371) :1880-1884
[8]   Viral dynamics in HIV-1 infection [J].
Finzi, D ;
Siliciano, RF .
CELL, 1998, 93 (05) :665-671
[9]   The Cln3 cyclin is down-regulated by translational repression and degradation during the G1 arrest caused by nitrogen deprivation in budding yeast [J].
Gallego, C ;
Garí, E ;
Colomina, N ;
Herrero, E ;
Aldea, M .
EMBO JOURNAL, 1997, 16 (23) :7196-7206
[10]   Cyclins, cyclin-dependent kinases and differentiation [J].
Gao, CY ;
Zelenka, PS .
BIOESSAYS, 1997, 19 (04) :307-315